The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level

Objective: To compare the Neuropeptide Y (NPY) levels in nonobese Polycystic Ovary Syndrome (PCOS) patients without insulin resistance and non-obese women without insulin resistance, in consideration of the psychopathologic conditions occurring in PCOS patients as well as the influence of these chan...

Full description

Bibliographic Details
Main Author: Mariza Yustina
Format: Article
Language:English
Published: Indonesian Society of Obstetrics and Gynecology 2012-07-01
Series:Indonesian Journal of Obstetrics and Gynecology
Online Access:http://inajog.com/index.php/journal/article/view/310
_version_ 1830193031470383104
author Mariza Yustina
author_facet Mariza Yustina
author_sort Mariza Yustina
collection DOAJ
description Objective: To compare the Neuropeptide Y (NPY) levels in nonobese Polycystic Ovary Syndrome (PCOS) patients without insulin resistance and non-obese women without insulin resistance, in consideration of the psychopathologic conditions occurring in PCOS patients as well as the influence of these changes in affecting NPY levels. Methods: The subject was fourteen PCOS patients and 20 non-obese normal women, both without insulin resistance. The measurements of blood NPY levels using the ELISA method and a psychology assessment using Symptom Check List 90 (SCL-90) were carried out. Statistical analysis was performed using SPSS 17. Results: From 20 PCOS patients included in this study, 6 subjects (30%) were detected as having psychopathologic problems through completion of the SCL-90 questionnaire, with a cut-off score of >70 points. Measurement of NPY levels using ELISA found a mean NPY level of 8.02 ± 3.92 (95% CI 2.39 - 18.66) in the PCOS group compared to a mean of 7.78 ± 4.31 pg/ml (95% CI 0.74 - 15.47) in the control group. No significant difference was found in the mean levels of NPY between the two groups. Statistical assessment using the Spearman 2-variable correlation test also found no significant correlation between NPY levels and the SCL-90, scores in the PCOS group. Conclusion: There was no significant difference in NPY levels between the PCOS group and control group. Thirty percent of non-obese PCOS patients without insulin resistance were identified as having psychopathologic conditions. But in this group of patients, the psychopathologic changes had no influence on the levels of blood NPY. [Indones J Obstet Gynecol 2012; 36-3: 125-9] Keywords: neuropeptide Y, PCOS, psychopathologic conditions
first_indexed 2024-12-18T00:05:56Z
format Article
id doaj.art-168459cb3c2048d9afb68ed20d8853bc
institution Directory Open Access Journal
issn 2338-6401
2338-7335
language English
last_indexed 2024-12-18T00:05:56Z
publishDate 2012-07-01
publisher Indonesian Society of Obstetrics and Gynecology
record_format Article
series Indonesian Journal of Obstetrics and Gynecology
spelling doaj.art-168459cb3c2048d9afb68ed20d8853bc2022-12-21T21:27:48ZengIndonesian Society of Obstetrics and GynecologyIndonesian Journal of Obstetrics and Gynecology2338-64012338-73352012-07-0112512910.32771/inajog.v36i3.310310The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y LevelMariza Yustina0Department of Obstetrics and Gynecology Faculty of Medicine University of Indonesia/ Dr. Cipto Mangunkusumo Hospital JakartaObjective: To compare the Neuropeptide Y (NPY) levels in nonobese Polycystic Ovary Syndrome (PCOS) patients without insulin resistance and non-obese women without insulin resistance, in consideration of the psychopathologic conditions occurring in PCOS patients as well as the influence of these changes in affecting NPY levels. Methods: The subject was fourteen PCOS patients and 20 non-obese normal women, both without insulin resistance. The measurements of blood NPY levels using the ELISA method and a psychology assessment using Symptom Check List 90 (SCL-90) were carried out. Statistical analysis was performed using SPSS 17. Results: From 20 PCOS patients included in this study, 6 subjects (30%) were detected as having psychopathologic problems through completion of the SCL-90 questionnaire, with a cut-off score of >70 points. Measurement of NPY levels using ELISA found a mean NPY level of 8.02 ± 3.92 (95% CI 2.39 - 18.66) in the PCOS group compared to a mean of 7.78 ± 4.31 pg/ml (95% CI 0.74 - 15.47) in the control group. No significant difference was found in the mean levels of NPY between the two groups. Statistical assessment using the Spearman 2-variable correlation test also found no significant correlation between NPY levels and the SCL-90, scores in the PCOS group. Conclusion: There was no significant difference in NPY levels between the PCOS group and control group. Thirty percent of non-obese PCOS patients without insulin resistance were identified as having psychopathologic conditions. But in this group of patients, the psychopathologic changes had no influence on the levels of blood NPY. [Indones J Obstet Gynecol 2012; 36-3: 125-9] Keywords: neuropeptide Y, PCOS, psychopathologic conditionshttp://inajog.com/index.php/journal/article/view/310
spellingShingle Mariza Yustina
The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
Indonesian Journal of Obstetrics and Gynecology
title The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
title_full The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
title_fullStr The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
title_full_unstemmed The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
title_short The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
title_sort psychopathology changes in non obese pcos women do not show any influence on neuropeptide y level
url http://inajog.com/index.php/journal/article/view/310
work_keys_str_mv AT marizayustina thepsychopathologychangesinnonobesepcoswomendonotshowanyinfluenceonneuropeptideylevel
AT marizayustina psychopathologychangesinnonobesepcoswomendonotshowanyinfluenceonneuropeptideylevel